Volume 13, Number 2—February 2007
Research
Community-associated Methicillin-resistant Staphylococcus aureus Isolates and Healthcare-Associated Infections1
Table 2
No. isolates | SCCmec | mecI | mecR1 (PB) | pvl | MLST | Clindamycin | Gentamicin | TMP-SMX | SCCmec type phenotype‡ |
---|---|---|---|---|---|---|---|---|---|
8 | IV | – | – | + | 8 | S | S | S | IV |
1 | IV | – | – | + | 1 | S | S | S | IV |
2 | IV | – | – | – | 8 | S | S | S | IV |
1* | IV | – | - | – | 8 | R | R | R | II |
5 | II | + | + | – | 5 | R | R | S | II |
4 | II | + | + | – | 5 | R | S | S | II |
1 | II | + | + | – | 8 | R | S | S | II |
1§ | II | + | + | – | 5 | S | S | S | IV |
1¶ | - | – | – | – | 5 | R | S | S | II |
*MRSA, methicillin-resistant Staphylococcus aureus; PB, penicillin-binding region;;MLST, multilocus sequence typing; R, resistant; S,
susceptible; TMP-SMX, trimethoprim-sulfamethoxazole.
†All isolates were associated with mecA and ccr2 genes.
‡Phenotype: as defined by the study case definition, according to antimicrobial drug susceptibilities (see Methods).
§SCCmec phenotype did not match genotype.
¶SCCmec was not located for this isolate.
1Findings from this investigation were presented in part at the 45th Annual International Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, USA, December 2005.
2Current affiliation: University of Southern California School of Pharmacy, Los Angeles, California
Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.